Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amphastar Pharmaceuticals (AMPH) Total Non-Current Liabilities (2016 - 2025)

Amphastar Pharmaceuticals has reported Total Non-Current Liabilities over the past 12 years, most recently at $810.5 million for Q4 2025.

  • Quarterly results put Total Non-Current Liabilities at $810.5 million for Q4 2025, down 3.3% from a year ago — trailing twelve months through Dec 2025 was $810.5 million (down 3.3% YoY), and the annual figure for FY2025 was $810.5 million, down 3.3%.
  • Total Non-Current Liabilities for Q4 2025 was $810.5 million at Amphastar Pharmaceuticals, down from $882.5 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for AMPH hit a ceiling of $933.8 million in Q3 2023 and a floor of $181.4 million in Q1 2021.
  • Median Total Non-Current Liabilities over the past 5 years was $765.4 million (2023), compared with a mean of $553.7 million.
  • Biggest five-year swings in Total Non-Current Liabilities: soared 350.37% in 2023 and later decreased 15.35% in 2024.
  • Amphastar Pharmaceuticals' Total Non-Current Liabilities stood at $210.4 million in 2021, then fell by 2.02% to $206.1 million in 2022, then surged by 320.87% to $867.4 million in 2023, then fell by 3.37% to $838.2 million in 2024, then fell by 3.3% to $810.5 million in 2025.
  • The last three reported values for Total Non-Current Liabilities were $810.5 million (Q4 2025), $882.5 million (Q3 2025), and $830.1 million (Q2 2025) per Business Quant data.